$19.97
-2.55-11.32%
At close: -
$19.97
0.000.00%
After Hours: Apr 4, 5:02 PM EDT
Comments
Loading...
Apellis Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:APLS | Benzinga
Apellis Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 6
EPS Estimate
$-0.420
Quarterly Revenue Estimate
$193.43M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$781.37M
Analyze the earnings history of Apellis Pharmaceuticals using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| APLS | Apellis Pharmaceuticals | -$0.54 | -$0.42 | — | — | $172.32M | $193.43M | — | — | 05/06/2025 | Get Alert |
| APLS | Apellis Pharmaceuticals | -$0.73 | -$0.40 | -$0.29 | 27.50% | $146.38M | $197.91M | $212.53M | 7.39% | 02/28/2025 | Get Alert |
| APLS | Apellis Pharmaceuticals | -$1.17 | -$0.30 | -$0.46 | -53.33% | $110.40M | $200.35M | $196.83M | -1.76% | 11/05/2024 | Get Alert |
| APLS | Apellis Pharmaceuticals | -$1.02 | -$0.32 | -$0.28 | 12.50% | $94.97M | $193.78M | $199.69M | 3.05% | 08/01/2024 | Get Alert |
| APLS | Apellis Pharmaceuticals | -$1.56 | -$0.52 | -$0.54 | -3.85% | $44.85M | $163.35M | $172.32M | 5.49% | 05/07/2024 | Get Alert |
| APLS | Apellis Pharmaceuticals | -$1.50 | -$0.69 | -$0.73 | -5.80% | $22.66M | $143.59M | $146.38M | 1.94% | 02/27/2024 | Get Alert |
| APLS | Apellis Pharmaceuticals | -$1.75 | -$0.85 | -$1.17 | -37.65% | $22.06M | $99.74M | $110.40M | 10.69% | 11/01/2023 | Get Alert |
| APLS | Apellis Pharmaceuticals | -$1.46 | -$1.32 | -$1.02 | 22.73% | $16.32M | $70.25M | $94.97M | 35.19% | 07/31/2023 | Get Alert |
| APLS | Apellis Pharmaceuticals | -$1.42 | -$1.46 | -$1.56 | -6.85% | $14.38M | $26.10M | $44.85M | 71.82% | 05/04/2023 | Get Alert |
| APLS | Apellis Pharmaceuticals | -$1.61 | -$1.57 | -$1.50 | 4.46% | $60.29M | $24.19M | $22.66M | -6.31% | 02/21/2023 | Get Alert |
| APLS | Apellis Pharmaceuticals | -$1.57 | -$1.45 | -$1.75 | -20.69% | $5.65M | $21.59M | $22.06M | 2.16% | 11/07/2022 | Get Alert |
| APLS | Apellis Pharmaceuticals | -$2.72 | -$1.36 | -$1.46 | -7.35% | $623.00K | $16.94M | $16.32M | -3.65% | 08/08/2022 | Get Alert |
| APLS | Apellis Pharmaceuticals | -$2.32 | -$1.32 | -$1.42 | -7.58% | $0.00 | $12.57M | $14.38M | 14.41% | 05/04/2022 | Get Alert |
| APLS | Apellis Pharmaceuticals | $0.93 | -$1.54 | -$1.61 | -4.55% | $250.00M | $8.78M | $60.29M | 586.67% | 02/28/2022 | Get Alert |
| APLS | Apellis Pharmaceuticals | -$1.79 | -$1.75 | -$1.57 | 10.29% | $646.00K | $7.22M | $5.65M | -21.75% | 11/08/2021 | Get Alert |
| APLS | Apellis Pharmaceuticals | -$1.57 | -$1.70 | -$2.72 | -60.00% | $0.00 | $810.00K | $623.00K | -23.09% | 08/09/2021 | Get Alert |
| APLS | Apellis Pharmaceuticals | -$2.29 | -$1.62 | -$2.32 | -43.21% | $0.00 | $2.27M | $0.00 | -100.00% | 04/28/2021 | Get Alert |
| APLS | Apellis Pharmaceuticals | -$1.77 | — | $0.93 | — | $0.00 | $96.09M | $250.00M | 160.17% | 02/25/2021 | Get Alert |
| APLS | Apellis Pharmaceuticals | -$1.09 | — | -$1.79 | — | $0.00 | — | $646.00K | — | 11/02/2020 | Get Alert |
| APLS | Apellis Pharmaceuticals | -$1.12 | — | -$1.57 | — | $0.00 | — | $0.00 | — | 07/31/2020 | Get Alert |
| APLS | Apellis Pharmaceuticals | -$0.87 | — | -$2.29 | — | $0.00 | — | $0.00 | — | 04/29/2020 | Get Alert |
Apellis Pharmaceuticals (APLS) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-28 | $-0.29 | $-0.40 | 27.5 % |
| Q3 | 2024-11-05 | $-0.46 | $-0.30 | -53.3 % |
| Q2 | 2024-08-01 | $-0.28 | $-0.32 | 12.5 % |
| Q1 | 2024-05-07 | $-0.54 | $-0.52 | -3.85 % |
Apellis Pharmaceuticals (APLS) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-28 | $212.53M | $197.91M | 7.39 % |
| Q3 | 2024-11-05 | $196.83M | $200.35M | -1.76 % |
| Q2 | 2024-08-01 | $199.69M | $193.78M | 3.05 % |
| Q1 | 2024-05-07 | $172.33M | $163.35M | 5.49 % |
FAQ
When is Apellis Pharmaceuticals (NASDAQ:APLS) reporting earnings?
Apellis Pharmaceuticals (APLS) is scheduled to report earnings on May 6, 2025. The last reported earnings were for reported on February 28, 2025 for Q4.
What were the latest earnings per share (EPS) for Apellis Pharmaceuticals (NASDAQ:APLS)?
The Actual EPS was $-0.29, which beat the estimate of $-0.40.
What were Apellis Pharmaceuticals’s (NASDAQ:APLS) revenues?
The Actual Revenue was $212.5M, which beat the estimate of $197.9M.
Browse earnings estimates, EPS, and revenue on all stocks.